The University of Queensland

Follow-up of patients with progressive multiple sclerosis treated with autologous Epstein Barr virus-specific T cell therapy (2018–2020)

Grant type:

Multiple Sclerosis Society of Queensland

Researchers:

• 

  Emeritus Professor Michael Pender

  Emeritus Professor
  

  Royal Brisbane Clinical Unit

  Faculty of Medicine

Funded by:

Multiple Sclerosis Society of Queensland